The Treatment of BPH Before Minimally Invasive Options

In this video, C. Shawn West, MD, a urologist with McIver Urological Clinic in Florida, outlines the historical treatment paradigm for benign prostatic hyperplasia (BPH), which was dominated by invasive surgical interventions such as transurethral resection and simple prostatectomy. Although these procedures were effective in relieving obstruction, they were often applied in a “one-size-fits-all” manner, regardless of disease severity or patient preference. This lack of therapeutic flexibility limited individualized care and exposed patients to unnecessary procedural morbidity.

West emphasizes that earlier technologies constrained urologists’ ability to tailor treatment, resulting in interventions that frequently carried significant functional consequences, including sexual dysfunction and prolonged recovery. Although outcomes were generally favorable from an obstruction standpoint, the trade-offs in quality of life were substantial. These limitations underscored the need for less invasive, patient-centered alternatives.

Over time, efforts to develop minimally invasive therapies initially stalled due to insufficient durability data from early modalities such as transurethral needle ablation and microwave therapy. However, recent technological advancements have led to a resurgence in minimally invasive surgical therapy development. West also highlights an ongoing gap in awareness among primary care physicians and patients, which may delay referral and contribute to irreversible bladder dysfunction—reinforcing the importance of earlier intervention.